GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Total Liabilities

Cognetivity Neurosciences (Cognetivity Neurosciences) Total Liabilities : $11.44 Mil (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Total Liabilities?

Cognetivity Neurosciences's Total Liabilities for the quarter that ended in Oct. 2023 was $11.44 Mil.

Cognetivity Neurosciences's quarterly Total Liabilities increased from Apr. 2023 ($9.52 Mil) to Jul. 2023 ($10.51 Mil) and increased from Jul. 2023 ($10.51 Mil) to Oct. 2023 ($11.44 Mil).

Cognetivity Neurosciences's annual Total Liabilities increased from Jan. 2021 ($0.76 Mil) to Jan. 2022 ($6.09 Mil) and increased from Jan. 2022 ($6.09 Mil) to Jan. 2023 ($9.48 Mil).


Cognetivity Neurosciences Total Liabilities Historical Data

The historical data trend for Cognetivity Neurosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Total Liabilities Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Total Liabilities
Get a 7-Day Free Trial 0.18 0.77 0.76 6.09 9.48

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.63 9.48 9.52 10.51 11.44

Cognetivity Neurosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cognetivity Neurosciences's Total Liabilities for the fiscal year that ended in Jan. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.893+(0+1.583
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=9.48

Total Liabilities=Total Assets (A: Jan. 2023 )-Total Equity (A: Jan. 2023 )
=2.108--7.368
=9.48

Cognetivity Neurosciences's Total Liabilities for the quarter that ended in Oct. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11.437+(0.998+-0.998
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=11.44

Total Liabilities=Total Assets (Q: Oct. 2023 )-Total Equity (Q: Oct. 2023 )
=0.355--11.082
=11.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019